Notable Upgrades: Apple (AAPL), Nektar Therapeutics (NKTR), Science Applications (SAIC), Nordson (NDSN)

Apple Inc. (AAPL) was reiterated an ‘Outperform’ by RBC Capital Markets analysts on Thursday. The broker also cut its price target on the stock to $130 from $140 saying they are lowering March-quarter iPhone units to 45 million units from 54 million to reflect incremental softness and recent production cuts. Nektar Therapeutics (NKTR) was reiterated […] View the full post at: Notable Upgrades: Apple (AAPL), Nektar Therapeutics (NKTR), Science Applications (SAIC), Nordson (NDSN) Related posts: Apple’s (AAPL) Short Interest Nosedives A123 Systems Surges on Joint Venture Battery Deal with China’s SAIC Motor Edward Zabitsky Recommends Selling Apple (AAPL) Short, $126 Target
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.